Biogen, Inc. (NASDAQ:BIIB)
Q2 2017 Earnings Call
July 25, 2017 8:00 am ET
Executives
Matthew Calistri - Biogen, Inc.
Michel Vounatsos - Biogen, Inc.
Michael D. Ehlers, M.D., Ph.D. - Biogen, Inc.
Paul McKenzie - Biogen, Inc.
Alfred W. Sandrock, Jr., M.D., Ph.D. - Biogen, Inc.
Jean-Paul Kress - Biogen, Inc.
Analysts
Geoff Meacham - Barclays Capital, Inc.
Eric Schmidt - Cowen & Co. LLC
Umer Raffat - Evercore ISI
Geoffrey C. Porges - Leerink Partners LLC
Ying Huang - Bank of America Merrill Lynch
Aharon Gal - Sanford C. Bernstein & Co. LLC
Robyn Karnauskas - Citigroup Global Markets, Inc.
Matthew K. Harrison - Morgan Stanley & Co. LLC
Alethia Young - Credit Suisse Securities (NYSE:USA) LLC
Terence Flynn - Goldman Sachs & Co. LLC
Michael J. Yee - Jefferies LLC
Cory W. Kasimov - JPMorgan Securities LLC
Jim Birchenough - Wells Fargo Securities LLC
Salim Syed - Mizuho Securities USA, Inc.
Andrew Peters - Deutsche Bank Securities, Inc.
Brian P. Skorney - Robert W. Baird & Co., Inc.